Literature DB >> 10734260

The Fukuyama congenital muscular dystrophy story.

T Toda1, K Kobayashi, E Kondo-Iida, J Sasaki, Y Nakamura.   

Abstract

Fukuyama congenital muscular dystrophy is one of the most common autosomal recessive disorders in the Japanese population, characterized by congenital muscular dystrophy in combination with cortical dysgenesis (micropolygyria). Recently, we have identified the gene responsible for fukuyama congenital muscular dystrophy on 9q31, which encodes a novel 461-amino-acid protein termed fukutin. Most Fukuyama congenital muscular dystrophy-bearing chromosomes are derived from a single ancestral founder (87%), and a 3 kb-retrotransposal insertion into the 3' untranslated region of this gene was found to be a founder mutation. Two independent point mutations causing premature termination confirmed that that this gene is responsible for Fukuyama congenital muscular dystrophy. Fukuyama congenital muscular dystrophy is the first human disease to be caused by an ancient retrotransposal integration. Fukutin contains an amino-terminal signal sequence, which together with results from transfection experiments suggests that it is an extracellular protein. Discovery of the Fukuyama congenital muscular dystrophy gene represents an important step toward greater understanding of the pathogenesis of muscular dystrophies and also of normal brain development.

Entities:  

Mesh:

Year:  2000        PMID: 10734260     DOI: 10.1016/s0960-8966(99)00109-1

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  RNAMotif, an RNA secondary structure definition and search algorithm.

Authors:  T J Macke; D J Ecker; R R Gutell; D Gautheret; D A Case; R Sampath
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

2.  Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.

Authors:  Charles H Vannoy; Lei Xu; Elizabeth Keramaris; Pei Lu; Xiao Xiao; Qi Long Lu
Journal:  Hum Gene Ther Methods       Date:  2014-05-02       Impact factor: 2.396

Review 3.  [Cardiac manifestations of muscular dystrophies].

Authors:  A Perrot; S Spuler; C Geier; R Dietz; K J Osterziel
Journal:  Z Kardiol       Date:  2005-05

4.  Founder effect of the C9 R95X mutation in Orientals.

Authors:  Vahid Khajoee; Kenji Ihara; Ryutaro Kira; Megumi Takemoto; Hiroyuki Torisu; Yasunari Sakai; Jia Guanjun; Park Myoung Hee; Katsushi Tokunaga; Toshiro Hara
Journal:  Hum Genet       Date:  2003-01-09       Impact factor: 4.132

5.  Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families.

Authors:  Wendy Chang; Thomas L Winder; Charles A LeDuc; Lynn L Simpson; William S Millar; Jeffrey Dungan; Norman Ginsberg; Stacey Plaga; Steven A Moore; Wendy K Chung
Journal:  Prenat Diagn       Date:  2009-06       Impact factor: 3.050

Review 6.  Dystroglycan glycosylation and muscular dystrophy.

Authors:  Christopher J Moore; Jane E Hewitt
Journal:  Glycoconj J       Date:  2008-09-05       Impact factor: 2.916

7.  Novel mutation in the fukutin gene in an Egyptian family with Fukuyama congenital muscular dystrophy and microcephaly.

Authors:  Samira Ismail; Ashleigh E Schaffer; Rasim O Rosti; Joseph G Gleeson; Maha S Zaki
Journal:  Gene       Date:  2014-02-13       Impact factor: 3.688

8.  Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression.

Authors:  Yoshihisa Ohtsuka; Motoi Kanagawa; Chih-Chieh Yu; Chiyomi Ito; Tomoko Chiyo; Kazuhiro Kobayashi; Takashi Okada; Shin'ichi Takeda; Tatsushi Toda
Journal:  Sci Rep       Date:  2015-02-09       Impact factor: 4.379

Review 9.  Muscular Dystrophy with Ribitol-Phosphate Deficiency: A Novel Post-Translational Mechanism in Dystroglycanopathy.

Authors:  Motoi Kanagawa; Tatsushi Toda
Journal:  J Neuromuscul Dis       Date:  2017

10.  Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice.

Authors:  Anthony Blaeser; Hiroyuki Awano; Bo Wu; Qi-Long Lu
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.